Increased alcohol use among pregnant and postpartum women during the COVID-19 pandemic was associated with autonomic nervous system dysregulation, known to negatively affect resilience to change and further exacerbate the ...
Jun 12, 2023
0
2
In a new national poll, Americans widely agreed that cigarettes are unsafe (84%) and addictive (87%), and yet a fifth (21%) reported smoking every day. The vast majority of people believe alcohol, opioids, and vapes are addictive, ...
Jun 9, 2023
0
3
Exposure to opioids under chronic pain conditions produces unique gene expression changes in brain regions associated with cognition, emotion, and reward, according to preclinical research conducted at the Icahn School of ...
Jun 9, 2023
0
54
For decades, efforts by police to seize illicit drugs have been a cornerstone strategy for disrupting drug markets and removing drugs from communities. But there's an unintended outcome when opioids are seized, a new study ...
Jun 8, 2023
0
13
A new study published in the Journal of the Society for Social Work & Research examines the impact of the COVID-19 pandemic on those responsible for helping the United States continue to function during a national crisis.
Jun 6, 2023
0
1
The 2023 Canadian wildfire season is off to a roaring start. In Alberta, there have been more than 560 wildfires so far —the highest recorded number of fires since 2018, and the season has only just begun. Tens of thousands ...
Jun 6, 2023
0
1
An overdose crisis is affecting children, adolescents and adults across the United States. Most drug overdoses in young people are caused by opioids, and specifically, fentanyl.
Jun 5, 2023
0
2
Fibromyalgia is common, affecting around 2% of people in the general population. The 2017 EULAR recommendations state that tramadol—a weak opioid—may be considered for pain management in fibromyalgia, but advise against ...
Jun 2, 2023
0
10
Contrary to expectations, the risk for relapses, overdoses and deaths related to substance use disorder didn't increase after a large-scale prison release in New Jersey, according to a Rutgers study.
Jun 2, 2023
0
65
The U.S. Food and Drug Administration has approved Brixadi (buprenorphine) extended-release injection to treat moderate-to-severe opioid use disorder.
May 31, 2023
0
5
